American University of Beirut   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Beirut Lebanon (1866)

Organization Overview

First Clinical Trial
2003
NCT00137501
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ala'a Sharara | Ali Shamseddine | American University of Beirut Medical Center | American University of Beirut Medical Center- Lebannon | American Univesity of Beirut | American Univesity of Beirut Medical Center | AUB | AUBMC | Bahman Hospital Beirut Lebanon

Active Ingredients

Drugs in Phase 4 Trials (31)

Bismuth Subcitrate Potassium (Pylera) (1 trial)

captafer (1 trial)

clarithromycin (biaxin) (1 trial)

clomifene (clomid) (1 trial)

dexlansoprazole (dexilant) (1 trial)

dexmedetomidine (precedex) (3 trials)

enoxaparin (lovenox) (1 trial)

ferric sulfate (1 trial)

follitropin alfa (1 trial)

glycopyrronium (robinul) (1 trial)

haloperidol (haldol) (1 trial)

magnesium citrate (1 trial)

menopausal gonadotropin (1 trial)

metronidazole (flagyl) (2 trials)

myoinositol (2 trials)

neostigmine (bloxiverz) (1 trial)

ondansetron (zofran) (1 trial)

phenylephrine (Prefrin) (1 trial)

polyethylene glycol (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

progesterone (progestasert) (1 trial)

rabeprazole (pariet) (2 trials)

sodium chloride (2 trials)

sodium picosulfate (1 trial)

sofosbuvir (sovaldi) (1 trial)

sugammadex (bridion) (1 trial)

tetracycline (tetrex) (1 trial)

triptorelin (Trelstar) (1 trial)

varenicline (chantix) (1 trial)

velpatasvir (Epclusa) (1 trial)

vitamin c (4 trials)

Drugs in Phase 3 Trials (17)

acetaminophen (tylenol) (1 trial)

deferasirox (exjade) (2 trials)

dienogest (natazia) (2 trials)

ferrous fumarate (1 trial)

ketoprofen (orudis) (1 trial)

lidocaine (xylocaine) (1 trial)

misoprostol (cytotec) (2 trials)

morphine (2 trials)

mosapride (citrate) (1 trial)

nefopam (1 trial)

nifedipine (procardia) (1 trial)

prilocaine (citanest) (1 trial)

sildenafil (viagra) (1 trial)

sucrose (1 trial)

sucrosomial iron (1 trial)

ursodeoxycholic acid (1 trial)

vitamin d3 (3 trials)

Drugs in Phase 2 Trials (14)

adalimumab (humira) (2 trials)

apraclonidine (iopidine) (1 trial)

betamethasone (celestone) (1 trial)

biotin (1 trial)

castor oil (1 trial)

compound 121564 (1 trial)

compound 2055269 (1 trial)

diltiazem (cardizem) (1 trial)

hydroxyprogesterone (Delalutin) (1 trial)

oxaliplatin (eloxatin) (1 trial)

perampanel (fycompa) (1 trial)

sp-420 (1 trial)

spd602 (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Phase 1 Trials (3)

letrozole (femara) (1 trial)

manuka honey (1 trial)

olive oil (1 trial)

Drugs in Other Trials (15)

caffeine (1 trial)

cocoa butter (1 trial)

esomeprazole (nexium) (1 trial)

fentanyl (Innovar) (1 trial)

gonapeptyl (1 trial)

lansoprazole (prevacid) (1 trial)

lysine (1 trial)

metformin (glucophage) (1 trial)

methylprednisolone (medrol) (1 trial)

nilotinib (tasigna) (1 trial)

oxytocin (syntocinon) (1 trial)

phosphorus (4 trials)

platelet rich plasma (1 trial)

propofol (diprivan) (1 trial)

sevoflurane (ultane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Agnosia (Phase 3)

Amyotrophic Lateral Sclerosis (Phase 2)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Avitaminosis (Phase 3)

beta-Thalassemia (Phase 3)

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cholecystitis (Phase 4)

Cholecystolithiasis (Phase 3)

Cholelithiasis (Phase 3)

Choroidal Neovascularization (Phase 1)

Colitis (Phase 4)

Colitis, Ulcerative (Phase 4)

Communicable Diseases (Phase 4)

Constipation (Phase 3)

Deficiency Diseases (Phase 4)

Diabetic Retinopathy (Phase 1)

Endometriosis (Phase 3)

Fetal Death (Phase 3)

Fissure in Ano (Phase 2)

Gallstones (Phase 3)

Heartburn (Phase 4)

Helicobacter Infections (Phase 4)

Hemosiderosis (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Hypotension (Phase 4)

Infant, Newborn, Diseases (Phase 3)

Infections (Phase 4)

Infertility (Phase 4)

Inflammation (Phase 4)

Inflammatory Bowel Diseases (Phase 4)

Insulin Resistance (Phase 3)

Intestinal Diseases (Phase 4)

Iron Metabolism Disorders (Phase 2)

Iron Overload (Phase 2)

Irritable Bowel Syndrome (Phase 3)

Leiomyoma (Phase 1)

Leukemia (Phase 1)

Lung Neoplasms (Phase 2)

Metabolic Diseases (Phase 2)

Motor Neuron Disease (Phase 2)

Mucositis (Phase 1)

Myofibroma (Phase 1)

Nausea (Phase 4)

Neovascularization, Pathologic (Phase 1)

Obstetric Labor, Premature (Phase 3)

Osteoporosis (Phase 3)

Pain, Postoperative (Phase 3)

Postoperative Nausea and Vomiting (Phase 4)

Pregnancy Complications (Phase 3)

Premature Birth (Phase 2)

Rectal Neoplasms (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Retinal Diseases (Phase 1)

Rickets (Phase 3)

Sclerosis (Phase 2)

Stillbirth (Phase 3)

Stomatitis (Phase 1)

Syndrome (Phase 3)

Tachypnea (Phase 2)

Thalassemia (Phase 4)

Tobacco Use Disorder (Phase 4)

Transient Tachypnea of the Newborn (Phase 2)

Ulcer (Phase 4)

Urinary Tract Infections (Phase 1)

Uveitis (Phase 2)

Vitamin D Deficiency (Phase 3)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 66
  • # of Trial APIs: 80